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OBJECTIVES: To determine the impact of COVID-19 pandemic social restriction measures on people 
with rheumatic and musculoskeletal diseases (RMDs) and to explore how people adapted to these 
measures over time.  
 
DESIGN: Mixed-methods investigation comprising a national online longitudinal survey and 
embedded qualitative study. 
 
SETTING: UK online survey and interviews with community-dwelling individuals in the East of England. 
 
PARTICIPANTS: People in the UK with RMDs, were invited to participate in an online survey. A 
subsection of respondents were invited to participate in the embedded qualitative study. 
 
PRIMARY AND SECONDARY OUTCOME MEASURES: The online survey, completed fortnightly over 10 
weeks from April 2020 to August 2020, investigated changes in symptoms, social isolation and 
loneliness, resilience and optimism. Qualitative interviews were undertaken assessing participant’s 
perspectives on changes in symptoms, exercising, managing instrumental tasks such a shopping, 
medication and treatment regimens, and how they experienced changes in their social networks. 
 
RESULTS:  703 people with RMDs completed the online survey. These people frequently reported a 
deterioration in symptoms as a result of COVID-19 pandemic social restrictions (52% reported increase 
vs. 6% reported a decrease). This was significantly worse for those aged 18 to 60 years compared to 
older participants (p=0.017). The qualitative findings from 30 individuals with RMDs suggest that the 
greatest change in daily life was experienced by those in employment. Although some retired people 
reported reduced opportunity for exercise outside their homes, they did not face the many competing 
demands experienced by employed people and people with children at home.  
 
CONCLUSIONS: People with RMDs reported a deterioration in symptoms when COVID-19 pandemic 
social restriction measures were enforced. This was worse for working-aged people. Consideration of 
this at-risk group, specifically for the promotion of physical activity, changing home-working practices 
and awareness of healthcare provision is important, as social restrictions continue in the UK.  
 
Keywords: COVID-19 pandemic; lockdown; rheumatology; musculoskeletal diseases; social isolation; 
occupational adaptation; qualitative; survey 
 
 
STRENGTHS AND LIMITATIONS OF THIS STUDY 
 
• This study reports the impact of COVID-19 social restrictions during the first COVID-19 
‘lockdown’ on the lived-experiences of people with RMDs. 
• This UK longitudinal survey of 703 people included an embedded qualitative study providing 
explanations on the quantitative results. 
• A breadth of important health domains were examined over the initial COVID-19 10-week 
social restriction period, including pain, social isolation and loneliness, resilience and 
optimism. 
• We only recruited UK residents so while the principles may apply to countries experiencing 







Rheumatic and musculoskeletal disease (RMDs) are a major cause of disability and reduced quality of 
life worldwide.[1] People with RMDs experience pain, joint stiffness, fatigue and muscle weakness 
with resultant physical disability. These symptoms are frequently managed with a combination of 
physical activity and medications, which for some people include immunosuppressive drugs. 
In March 2020, the World Health Organization (WHO) declared the outbreak of a novel coronavirus 
disease SARs-CoV-2 (COVID-19) to be a pandemic. On 16th March 2020, the UK government instructed 
all people aged 70 years and over to self-isolate in their homes for up to four months. This was 
extended to all people on 23rd March for an initial three-week period. People who were taking 
immunosuppressant medications or with medical comorbidities were instructed to maintain strict 
self-isolation principles (often referred to as shielding) for an extended period of at least 12 weeks 
(Supplementary File 1).  
 
At the outset, there was concern that people with RMDs may be particularly vulnerable to the 
unintended consequences of these ‘lockdown’ measures. They are recognised to be at increased risk 
of social isolation, through poor social support,[2] the frequent presence of other medical 
conditions[3,4] and functional disability.[5] Social isolation itself can affect levels of physical disability, 
psychological distress and pain in RMDs.[6] The loss of exercise opportunities, a key component of 
self-management programmes, risked increasing levels of disability and reducing mental wellbeing. 
COVID-19 pandemic measures also significantly impacted on routine healthcare access and NHS 
services.[7,8] Prior to this study, the resilience of this group to these enforced changes was unknown, 
as were likely long-term impacts. 
 
This study explores the impact of COVID-19 pandemic social restriction measures on people with 
RMDs and determines how people adapted to these measures over time. Our aim was to provide 
insight into the challenges and potential impacts of those most at risk, and to make recommendations 




METHODS AND ANALYSIS 
 
Design 
Mixed-methods investigation comprising a national online longitudinal survey and embedded 
qualitative study. The study is reported in accordance with the STROBE statement for reporting 
observational studies[9] and the COREQ statement for reporting qualitative research.[10] 
Survey Study 
Cohort and recruitment 
We invited participants who self-reported a diagnosis of chronic (three months or longer) RMDs 
(disease of the bone, joint or muscle), and who lived in the UK to participate in an online survey.  
We used three approaches to recruit potential participants. Firstly, we approached patient-based 
organisations (Versus Arthritis, Arthritis Action, Royal Osteoporosis Society, National Rheumatoid 
Arthritis Society, National Ankylosing Spondylitis Society, Fibromyalgia UK, Age UK, PainConcern and 
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Scope). All agreed to disseminate an invitation to the survey via their online patient forum or as an 
email. Secondly, we contacted members from an inception cohort of 1,396 people with inflammatory 
arthritis – the Norfolk Arthritis Register (NOAR).[11] Finally, we used research team members’ Twitter 
accounts to publicise the study.  
Data collection 
An online survey administered through the Qualtrics platform (Qualitrics XM, 
https://www.qualtrics.com/uk/) was provided to all participants. The survey is presented in 
Supplementary File 1. Participant consent was obtained through the platform before proceeding to 
the study survey. The survey collected information on: 
• age, gender, ethnicity, duration of symptoms, type of RMD, medical co-morbidities. 
• clinical disease activity.  
• changes in medication use, access to healthcare support, physical activity, disease symptoms 
since COVID-19 lock-down.  
• Clinical Health Assessment Questionnaire (CLINHAQ)[12] to assess disability and symptom 
status including: pain, fatigue, sleep, anxiety. 
• the Lubben Social Network Scale 6[13] – short assessment of social isolation. 
• University of California, Los Angeles (UCLA) three-item loneliness scale.[14] 
• 6-item Brief Resilience Scale (BRS-6).[15] 
• revised Life Orientation Test (LOT-R).[16] 
We opened Round 1 (baseline) recruitment from 28th April 2020 to 27th May 2020. We sent tweets 
weekly during Round 1 recruitment period. For those who completed Round 1, we sent the same 
survey at two-week intervals to investigate how symptoms, social isolation, loneliness, resilience and 
optimism changed over time (Rounds 2 to 6).  We sent a reminder email to participants who missed a 
subsequent round. The final survey was completed on 20th August 2020. 
Data analysis 
 
The analysis first addressed the perceived changes in symptoms since the start of lockdown in 
response to the question, “How have your symptoms been since the current COVID measures 
started?”. The responses were scored as decreased, stable, or increased. The influence of possible 
explanatory variables on the categories of symptom response was  assessed through chi-squared 
tests. Data were analysed using R (R Core Team[17]).  
 
A second analysis examined whether there were any prospective changes over the 10-week 
observation period in variables (pain, fatigue, anxiety, sleep, social networks, loneliness, resilience, 
optimism) that could be sensitive to change as the UK Government guidelines on social restriction 
measures altered (Supplementary File 2). There was a focus on differences in the two age groups (18-
60 years and 60+ years) with the cut-off chosen to approximate to ‘working’ (n=351) and ‘non-working’ 
groups (n=351). Mixed models were used to analyse repeated data from the same participants. Time 
was included as a fixed-effect and ‘participant ID’ as a random-effect. All analyses were conducted in 
R using the ‘clmm’ function in the ‘ordinal’ package[18] for ordinal response variables or the ‘lmer’ 




The qualitative study was an embedded interview study which aimed to explore the subjective 
experiences of people with RMDs during COVID-19 pandemic social restrictions.   
 




Survey participants recruited through NOAR were offered the option to take part in interviews; 137 
expressed an interest. We designed a purposive sampling strategy, recruiting to achieve variation in 
age and gender, recognising that rheumatoid arthritis (RA) is more common in women and people 
aged over 40 years. A sample size of 25 to 30 was planned to support data collection in the window of 
guidance on self-isolation.  This sample target was sufficient to enable robust themes to be developed.  




The interview topic guide (Supplementary File 3) took a narrative approach, starting with open 
questions on everyday life and then focused on the participant’s perspective on changes in symptoms, 
exercising, managing instrumental tasks such a shopping, medication and treatment regimens, and 
how they experienced changes in their social networks. Questions were reviewed by clinical and lay 
colleagues for clarity and relevance. Participants were approached by two researchers (LB, PB) over 
the telephone or email and received study information 72 hours prior to interview. All gave recorded 
verbal or written consent before the interview commenced.  All interviews were conducted by two 
experienced qualitative researchers (LB, PB) over the telephone due to COVID-19 restrictions and were 
audio recorded for transcription. Interviews lasted between 30 and 90 minutes; average duration was 




Data were analysed using a thematic analysis approach guided by the six-steps outlined by Braun and 
Clarke.[20] As a first step, interviews were transcribed and read to aid familiarization with the data. 
Two researchers (LB, PB) coded the data in NVivo 12. During coding, descriptive categories were 
identified relating to symptom attribution, changes to everyday life and wellbeing, narrative of 
vulnerability, and risk management. Frequent researcher and multidisciplinary meetings led to 
interpretive themes.[21] To enhance the dependability and confirmability of the results, peer and 
participants validation was completed.[22] Emerging themes and categories were shared across the 
research team and rheumatology health practitioners. Interview participants were sent a summary of 
key themes over email, followed by a phone call to each seeking feedback during August-September 
2020. There was strong resonance between the themes and participants’ experiences.  
 
The qualitative data were reviewed alongside the survey data to provide detailed explanations of 
experience of symptoms and wellbeing since restrictive measures commenced. Through this, an 
interpretative synthesis of results from each research methodology was presented using a mixed-
methods approach.   
 
 
PATIENT AND PUBLIC INVOLVEMENT 
 
Patient involvement began during protocol development stage of the study protocol and continued 
throughout. A patient-member (SW) provided her personal insights on the questions posed in the 
survey and qualitative topic guide. She provided advice into the interpretation of the survey and 
interview analysis. Our patient member assisted in the preparation of the final paper. She will 
continue to support dissemination through the preparation of public documents and social media 









In total, 703 respondents (574 females, 126 males, three others or non-binary) were recruited (262 
from NOAR and 441 from the wider-UK base). Their characteristics are summarised in Table 1. The 
majority of respondents were aged 51 to 70 (508/703; 72.3%) and residing in England (660/703; 
93.9%). A range of inflammatory and non-inflammatory diseases were represented with RA (44.2%) 
and osteoarthritis (21.6%) reported most frequently. There were no important differences in the 
characteristics or responses in the NOAR and non-NOAR identified RA patients, and their data were 
pooled for analysis.  
Table 2 illustrates respondent’s symptoms at baseline compared with before the imposition of the 
COVID-19 pandemic social restriction measures. In total, 365 (52%; 95% CI: 49% to 56%) reported an 
increase in symptoms related to their RMD, 287 (41%; 95% CI: 37% to 45%) reported that they had 
stayed the same and 45 (6%; 95% CI: 5% to 9%) reported decreased reduction in symptoms. 
Age had a significant influence on the change in symptoms, with a higher proportion of younger 
respondents (age ranged 18 to 60 years) reporting an increase in symptoms (p=0.017). As might be 
expected, people who experienced an increase in symptoms were more likely to have changed their 
medication (p<0.001) and have needed to access medical advice (p<0.001). Physical activity also varied 
according to the change in reported symptoms (p<0.001): those who reported that their symptoms 
had increased also reported a decreased level of physical activity (Table 2).  
Follow-up assessment 
Approximately 25-30% of the participants were lost to attrition over the course of the study. At the 
second timepoint (week=2), there were 525 participants, at week=4 there were 506, at week=6 there 
were 540, at week=8 there were 521 and at week=10 there were 491 participants. Supplementary 
File 4 compares the characteristics of participants at baseline and week=10 and indicates that they 
were similar. Figure 1 and Figure 2 illustrate the changes in responses over 10 weeks stratified by age 
(the strongest predictor of the increased level of symptoms). For all variables examined (symptoms, 
supportive social networks, loneliness, resilience and optimism), the younger age groups (18 to 60 
years) fared worse than the older group (60 years plus) across all time points. Levels of optimism 
amongst the younger age groups fell into the range that is classified as ‘low’. For the 18 to 60 years 
age group, there was a significant improvement in the levels of pain (p<0.001) and sleep (p<0.001), 
over the 10-week period, whilst anxiety levels (p=0.769) and fatigue (p=0.920) stayed the same. The 
60 years plus age group had significant improvements in pain (p<0.001) and fatigue (p=0.002) but 
sleep (p=0.080) and anxiety (p=0.610) stayed the same over the 10 weeks (Figure 1). The size of any 
improvements was marginal in both age groups. In contrast, feelings of social isolation intensified (18 
to 60 years: p<0.001; 60 years plus: p<0.001), and levels of resilience (18 to 60 years: p<0.001; 60 years 
plus: p<0.001) and optimism were significantly reduced (18 to 60 years: p=0.008; 60 years plus: 
p=0.009; Figure 2) but, the effect sizes were, again, small and unlikely to be of clinically relevant.  
Qualitative Study 
Interviews were undertaken with 26 participants between 27th May 2020 to 19th June 2020. The 
sample consisted of nine men and 17 women, with a mean age of 59 years (range: 29 to 83 years). 
Eighteen participants were diagnosed with RA, five with psoriatic arthritis, two with polymyalgia 
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rheumatica and one with inflammatory polyarthritis.  At the time of the baseline survey, 14 had 
reported increased symptoms, nine stable symptoms and three decreased symptoms (Table 3). 
 
Most participants described themselves as shielding, although there was variation in interpretation 
and adherence to the formal guidelines. There were narratives of resilience, acceptance and adaptive 
coping strategies:  
I put up a little poster just to remind myself that I can only change what I am able to change.  
I just need to try and accept what I can’t change.  [RMD1 Female 50-54] 
Nonetheless, most highlighted challenges or stresses associated with the COVID-19 pandemic. In 
some, this was accompanied by reported worsening symptoms, including increased pain, stiffness and 
fatigue. Not all participants directly attributed their experience of symptoms to the COVID-19 context: 
“My arthritis has flared up. I don't know if it's the change in situation or it was going to happen 
anyway.”  However, many spoke about reasons related to the pandemic which they perceived had 
underpinned symptom changes. Several speculated that a combination of these factors may have 
been at play. The reasons are outlined thematically below and summarised in Table 4.  
Accessing health care  
Many participants described ‘holding on’ to concerns about their disease because they did not want 
to trouble health services for fear of burdening the service, stating staff might be too busy due to 
COVID-19.  Some had decided to miss blood tests due to anxiety around exposure to infection. Others 
were self-managing their symptoms:  
If I get any breakthrough pain where I’m really not happy, I can take two of my tramadol 
and…I take nortriptyline at night and I make sure that I’m getting a decent night’s sleep. I’ve 
just been doing a lot of self-care. [RMD26 female 55-59] 
 
Health concerns were also sometimes not reported due to postponed or cancelled appointments. 
There was a commonly expressed acceptance of this situation, feeling that others are ‘worse off’ at a 
time of crisis: They cancelled my appointments…under the circumstances, you accept it…and think 
well, there’s people who are suffering and I’ll just stand by.  [RMD6 male 70-74] 
However, missing or postponed appointments created anxiety and a sense of detachment from 
healthcare support for some, compounding delayed advice seeking:  “I would have brought it up [at 
postponed appointment] and it would have been good to discuss those things, and you do worry”   
[RMD13 female 30-34].  Some had telephone appointments instead and although many preferred this, 
feeling it to be safer during the pandemic, some said that telephone appointments did not substitute 
entirely for face to face contact: “They can't see the pain you're in; they can't feel your joints, they 
can't do any of that…does make everything so much trickier”  [RMD23 female 45-49]. Others explained 
that they avoided raising what they thought of as smaller concerns during a telephone call. One person 
described a physiotherapy telephone appointment which they acknowledged had been helpful, but 
also said “[I] need human intervention for my body” [RMD10 female age 55-59]. 
 
Physical activity   
Shielding instructions, lockdown and fear of catching COVID-19 meant many interviewed participants 
reported being much more sedentary and not leaving the house at all. The most common attribution 
for symptom change, including pain, stiffness and fatigue, was reduced activity:  “I think that’s just 
lack of movement, the lack of being able to move about.  I think, over time, your body just shuts down 
due to lack of mobility”  [RMD10 female age 55-59]. 
Some discussed reduced motivation or limited opportunity to be able to engage in exercise: “ I used 
to go to the gym a lot, just to force myself.  But they’re all closed”  [RMD22 male 45-49]. Reduced 
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activity was also linked to disruption of everyday routine. This was more often discussed by those of 
working age who described ceasing a regular daily walk or cycle commute to work, or being on their 
feet, not only in manual jobs but also within the context of office-based work:     
Obviously, with me not working, then that’s a huge change, I actually spend my life going 
from one of the departments to another… I would say my exercise routine is pretty rubbish, 
I’ll be honest I have put some weight on during lockdown. That could be part of [worse 
symptoms], let’s face it.”   [RMD1 female 50-54] 
 
None reported having received specific advice about maintaining exercise for joint health at the time 
of interview, but a number were trying to substitute with exercise at home, (e.g. using a treadmill, 
online classes or walking round the garden). Exercising while avoiding contact with others was even 
more challenging without access to a private garden space:  
 
I’ve got a long balcony here, it’s about 100 yards long. So I should walk round there, but 
again, you’ve got to restrict that, because you never know if you’re going to meet someone 
the other way.  There isn’t two metres to pass….you find you’re just getting stiffer and stiffer.  
[RMD6 male 70-74] 
Home work-space and tasks at home 
Several interviewees explained they were working from home in environments which were far from 
ideal for the maintenance of good joint health, for example using a dining room chair and laptop rather 
than a desktop computer and office chair. Many envisaged home working for the foreseeable future. 
Levels of support and provision of equipment from employers was variable. Some employers had 
made swift efforts to prioritise provision of suitable equipment. However others had not received this 
support, and one participant was hesitant to complain for fear of losing their job at a time of job 
insecurity: 
I'm just sitting at the kitchen table with my laptop. [My employer] said they couldn't do 
anything because there were so many of us that weren't at work. I was just like well, I'll just 
get on with it then, because I kind of need my job.   [RMD23 female 45-49] 
In response to exacerbation of pain, some interviewees had purchased more ergonomic equipment 
themselves, while others felt they did not have the space to accommodate this kind of office set-up 
within their home. 
A few participants who were shielding discussed no longer having access to assistance with household 
tasks which had adversely impacted on their physical or mental health. A few spoke of pacing out 
household activities but had not received professional advice on this. 
Wellbeing  
Descriptions of low mood, isolation and boredom were common in the interviews. Many explained 
they were anxious about being in a clinically-vulnerable group, and also reported a sense of being left 
behind or forgotten about. Many expressed worries about the future and some felt they would 
continue staying at home, regardless of relaxation of guidelines.  A few said only a vaccine would make 
them feel ‘safe’.  Some made an explicit direct link with pain and fatigue symptoms, speculating for 
example that increased pain may be linked to stress surrounding their current situation. Others 
commented on the effect on their fatigue levels: “I’ve felt more tired, but I think that is because I felt 
more anxious and I haven’t slept so well…..I’d say it’s more linked to worrying about COVID” [RMD11 
female 50-54]. 
For some with caring responsibilities, increased demands and stress associated with managing 
multiple roles at home, working while schools were closed, was identified as having contributed to 
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symptom flare-up. There was also additional stress around decision-making and risk assessment in the 
context of family life, managing dilemmas about protecting their own health against wider family 
wellbeing. 
It’s been exhausting, absolutely exhausting. I was getting [child] to try and do his work, but 
he really needs one-to-one because he gets bored so quickly.  So that became a bit of a 
nightmare… and then working in the evening to kind of catch up….no way of, if my arthritis is 
really bad, of just resting.  [RMD23 female 45-49] 
Improving or stable symptoms 
In those who perceived no change in their condition, some attributed this to it having been in a stable, 
long-term state, for instance with disease already well-controlled by medication or conversely was 
“already bad”.  One participant who reported stable symptoms credited, in part, the support he had 
received from his employer prioritising him to receive appropriate office equipment for working at 
home. Others attributed their stable condition to maintaining routine, exercise and other protective 
coping behaviours: [My symptoms] seem to be about the same really.  I know if I sit about I’ll get stiff, 
so I do an exercise programme every day and try to keep myself moving around.”  [RMD16 female 75-
79] 
A small number of those interviewed explained that their symptoms had markedly improved as a 
consequence of COVID-19 measures. One cited better opportunity and motivation to take more 
exercise such as walks, or joining children for daily exercises. Another participant described benefitting 
from being at home and a slower pace of activity, and that shielding had offered a period of respite 
during which they were better able to cope with their condition and prioritise self-care:  
I’m furloughed….Having the time to just be at home, no one’s expectations, my body has a 
chance to heal and find some balance… it makes you wonder.  There's obviously no cure for 
RA at the moment but it does make you, you know, that emotional health is so key. [RMD21 
female 45-49] 
 
Supplementary File 5 provides a summary of an interpretive synthesis of results, with interview 
findings, offering an explanatory insight into potential reasons for changes identified through the 






Within the survey cohort, we found that people with RMDs frequently reported a deterioration in pain 
and symptoms, in addition to greater social isolation, loneliness and reduced optimism to their 
circumstances. This was significantly worse for those aged 18 to 60 years in comparison to older 
participants. The qualitative findings suggest that more types of change to daily life was experienced 
by those in employment. Although some retired people reported reduced opportunity for exercise 
outside the home, they did not face the many competing demands experienced by employed people 
and people with children at home.  
 
Relationship to previous evidence 
 
Recently, Persiani et al[23] and Garrido-Cumbrera et al[24] reported their findings of the impact of 
the first COVID-19 pandemic ‘lockdown’ in with people with RMDs. These findings reflect those of our 
UK cohort which illustrated a reduction in physical activity and increase in pain, particularly amongst 
people aged 50 to 70 years and in work.[23] and poor lifestyle habits negatively impacting on overall 
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physical and mental health.[24] These findings may be attributed to a disruption in their normal 
working patterns, changes in their home environment and loss of social networks. Our qualitative 
interviews indicated that the enforced COVID-19 pandemic social restrictions led to stressful changes 
in working routine, the addition of extra roles within the home (e.g. through home schooling) and 
deleterious workstation ergonomics due to lack of space and equipment. The latter point may be 
particularly important. Where occupational health requires work-station assessments for ergonomic 
safety, these were not practical in this phase of the pandemic. As people with pre-existing RMDs are 
particularly sensitive to the negative impacts of poor static postures, changes in workspace and 
working hours may have accounted for these reported physical responses.[25] As homeworking 
continues, employers should be aware of this challenge for employees with existing RMDs, to help 




The findings have implications for clinical practice. Firstly, the cohort we recruited largely 
demonstrated persistence in their worsening symptoms over time. As the qualitative research 
highlighted, reluctance to engage with health services, particularly during times of higher perceived 
risk, may mean that individuals are less likely to seek help for physical and mental health or only seek 
help when their symptoms become more severe, which may be more challenging to manage. 
Advertising and promoting services and how to access these may therefore be important strategies 
across primary and secondary care services to negate this issue. Secondly, due to changes in daily 
routine and increased symptoms, there may be greater disability within this population. Support to 
encourage resumption of physical activity routines and encouraging activity and engagement may be 
important for all.[26,27] Finally, these findings indicate that younger, working aged-people with RMDs 
were particularly affected by COVID-19 pandemic restrictions. Specific consideration of the impact on 
these individuals should be considered as they, potentially unexpectedly, may be at considerable risk 
of poorer musculoskeletal outcomes compared to older individuals. Employers should ensure that 
their workers, whilst working from home, have suitable risk assessments and provision of equipment 
to minimise the risks of exacerbating musculoskeletal pain, particularly for those with pre-existing 
RMDs.  
 
In the months after the data for this paper were collected (August 2020), some enforced changes have 
been lifted. However, for many people in the UK and internationally, measures to restrict social 
activity remain and their impacts are ongoing. The findings from this study therefore remain 
pertinent.[28] Furthermore, whilst some activities can be recommenced, such as attending hospital 
appointments and communal exercise, many people reported longer-term concerns regarding their 
risk of COVID-19 and have refrained from resuming their normal routines. Additional support may be 
required to encourage individuals with the greatest anxiety to return to some of these social pursuits. 
This will be particularly important to avoid problems associated with social isolation, once longer-term 
restrictions are lifted. Previous literature has demonstrated the association between social isolation 
and higher incidence of cardiovascular disease,[29,30] mental conditions,[31] dementia[32] and 
mortality.[33]  
 
Strengths and limitations 
 
This study is a large, national cohort of individuals with RMDs. The mixed-methods approach provides 
novel and important real-time exploratory and explanatory findings to the changes in symptoms that 
this cohort reported during the initial 10 weeks of COVID-19 pandemic restrictions. Method 
triangulation[34] led to a more comprehensive understanding of the experiences of this specific group 
of people who may be considered particularly at risk of unintended consequences from social 




Whilst these are key strengths, the study presents with three important limitations. Firstly, whilst we 
can report the self-reported levels of disability and impairment, the sample were self-selecting when 
completing the survey. Whilst the characteristics of this cohort are typical of those with RMDs,[35] 
responder bias may have an impact on the external validity of these findings. Secondly, whilst we are 
able to make assumptions based on a cohort that includes a range of different RMDs, we 
acknowledged that only a small proportion of the population were BAME and we did not collect data 
to assess the respondents’ level of social deprivation. Previous literature has highlighted these two 
factors to be potentially important in determining COVID-19 prognosis.[36] Including these groups 
may have provided a different description of the behaviours and perceptions of these individuals 
towards COVID-19 and the impact on their symptoms. Finally, the qualitative study recruited people 
from the NOAR cohort who had also completed the survey. These were all patients with inflammatory 
rheumatological conditions. It remains unclear whether the responses those individuals included in 






People with RMDs frequently experienced deterioration in pain and symptoms when COVID-19 
pandemic social restriction measures were enforced. As the restrictions continued over the following 
10-weeks, levels of social isolation and loneliness increased and optimism decreased. These changes 
were greater among those aged 18 to 60 years when compared with older age groups. Close attention 
to those at risk through the promotion of physical activity, changing home-working practices and 
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Table 1: Respondent characteristics and responses to health provision access from online survey at 
baseline  
Characteristics Frequency (%) 
N 703 
Gender  Female 574 (82.0) 
Male 126 (18.0) 
Non-binary 1 (0.1) 
Prefer to self-describe 1 (0.1) 
Prefer not to say 1 (0.1) 
Age 18-30 21 (3.0) 
31-40 44 (6.3) 
41-50 113 (16.1) 
51-60 173  (24.6) 
61-70 203 (28.9) 
71-80 132 (18.8) 
80+ 16 (2.3) 
Region of respondent England 660 (93.9) 
Scotland 21 (3.0) 
Wales 19 (2.7) 
Northern Ireland 2 (0.3) 
Ethnic Group White 682 (97.8) 
Mixed/Multiple ethnic group  4 (0.6) 
Asian 7 (1.0) 
Black, African, Caribbean 3 (0.4) 
Arab 1 (0.1) 
RMD Diagnosis Rheumatoid Arthritis   311 (44.2) 
Osteoarthritis   152 (21.6) 
Mechanical low back pain   70 (9.9) 
Fibromyalgia   68 (9.6) 
Psoriatic Arthritis   64 (9.1) 
Inflammatory Polyarthritis  63 (8.9) 
Hypermobility   40 (5.6) 
Specific RMD diagnosis not reported  33 (4.7) 
Connective tissue disease (e.g. Lupus, 
Scleroderma, Myositis) 
25 (3.5) 
Ankylosing Spondylitis 22 (3.1) 
Osteoporosis  18 (2.5) 
Polymyalgia Rheumatica 10 (1.4) 
Ligament/Tendon Injury/Bursitis  9 (1.3) 
Neck pain  6 (0.8) 
Gout  5 (0.7) 
Other 63 (8.9) 
How have your RMD symptoms been 
since the COVID measures started? 
Decreased 45 (6.5) 
Stayed the same 287 (41.1) 
Increased 365 (52.4) 
Pain (Scale: 0-10) Mean (SD) 4.8 (2.6) 
General Health (Scale: 0-10) Mean (SD) 4.1 (2.4) 
Total Lubben Social Network Score 
(Scale: 0-30) 
Mean (SD) 14.8 (5.5) 
Total UCLA Loneliness (Scale: 3-9) Mean (SD) 5.1 (2.0) 
Difficulty accessing medication Yes 82 (11.7) 
No 616 (88.3) 
Yes 309 (44.3) 
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Required someone to help access 
medications 
No 389 (55.7) 
Changed medications since COVID-19 
outbreak 
Yes 103 (14.8) 
No 595 (85.2) 
Required to seek advice from a health 
professional on condition 
Yes 252 (36.1) 
No 446 (63.9) 
Who did you contact General Practitioner 158 (22.3) 
Practice Nurse/GP Nurse Practitioner 23 (3.2) 
Rheumatology Department 97 (13.7) 
Physiotherapy or Occupational Therapist 16 (2.3) 
Pharmacist 16 (2.3) 
Hospital Department (non-RMD)  10 (1.4) 
A&E  3 (0.4) 
Private chiropractor, osteopath or 
massage therapist  
1 (0.1) 
Royal Osteoporosis Society  1 (0.1) 
Endocrinology Department 7 (1.0) 
Pain Clinic 2 (0.3) 
Counsellor or Health Psychologist 2 (0.3) 
Massage Therapist 1 (0.1) 
Podiatrist 1 (0.1) 
Nutritionist  1 (0.1) 
NHS 111  2 (0.3) 
How easy has it been to get advice? 
(Scale: 0-10) 
(Mean (SD) value. scale 0-10) 4.8 (3.3) 
A&E- accident and emergency; CI – confidence intervals; JIA – Juvenile Inflammatory Arthritis; NHS – National 
Health Service; RMD - rheumatic and musculoskeletal diseases; SD – standard deviation; UCLA – University of 






Table 2: Association at baseline between rheumatic and musculoskeletal disease (RMD) symptoms 
and selected participant characteristics and questionnaire responses.  
 “How have your symptoms been since the current 
COVID measures started?” 
Chi-squared test of 
association with outcome 
(symptoms) 
 Decreased Stable Increased p-value 
n (%) 45 (6) 287 (41) 365 (52)  
Age group    p=0.017 
18-60 22 (6) 125 (36) 200 (58)  
60 plus 33 (7) 162 (46) 165 (47) 
Gender    p=0.11 
Male 8 (7) 60 (49) 54 (44)  
Female 37 (6) 224 (39) 311 (54) 
RMD diagnosis*    p<0.001 
RA 17 (5) 155 (48) 149 (46)  
IA 4 (10) 24 (60) 12 (30) 
PsA 4 (6) 22 (34) 38 (59) 
Other 19 (7) 83 (31) 166 (62) 
Situation    p=0.880 
At home 24 (7) 141 (40) 191 (54)  
Self-isolating 8 (7) 49 (40) 64 (53) 
Shielding 13 (6) 97 (44) 110 (50) 
Difficulty accessing 
medication? 
   p=0.103 
Yes 4 (5) 26 (32) 52 (63)  
No 41 (7) 261 (42) 313 (51) 
Change medication?    p<0.001 
Yes 9 (9) 21 (20) 73 (71)  
No 36 (6) 266 (45) 292 (49) 
Consult health 
professional? 
   p<0.001 
Yes 15 (6) 64 (25) 172 (69)  
No 30 (7) 223 (50) 193 (43) 
Physical activity    p<0.001 
Decreased 31 (7) 141 (30) 302 (64)  
Same 3 (3) 89 (75) 26 (22) 
Increased 11 (10) 57 (54) 37 (35) 
Data are frequency (%) unless stated otherwise; RMD = Rheumatic and musculoskeletal diseases  
* RA=Rheumatoid arthritis, IA=Inflammatory arthritis, PsA=Psoriatic arthritis, Other=mainly Osteoarthritis 




Table 3: Interview sub-sample characteristics (N=26) 
Characteristics Frequency 
Gender  Female 17 
Male 9 







Ethnic Group White 26 
RMD Diagnosis Rheumatoid Arthritis   18 
Psoriatic Arthritis   5 
Inflammatory Polyarthritis  1 
Polymyalgia Rheumatica 2 
How have your RMD symptoms been 
since the COVID measures started? 
(reported at baseline) 
Decreased 3 
Stayed the same 9 
Increased 14 













Holding on to concerns 
I don’t like to worry them, they’ve got enough to do … It’s something that I feel I can manage until when this is all over hopefully I’ll get an 







I think that’s something I feel like I’ve missed out on with the lockdown is, I would actually quite have liked to have some proper physio, 
especially on the knees and that.  Because the swelling just doesn’t seem to want to go, as much as I poke and prod it and things like that.  [RMD 
10 female age 50-59] 
 
It was planned for me to have an MRI scan on my neck, but then this all happened and it’s just sort gone out the window….  It’s quite hard, day-
to-day, with the pain levels in my neck, but under the current situation, I would rather put up with the pain than put myself at risk by going into a 
hospital.  [RMD20 male age 50-55] 
 
Telephone appointments Where I’ve missed out because of the lockdown, is that although when I phoned the rheumatology department they’ve been really helpful, it’s 
not like having proper management.  So all of the questions that I would normally have asked, I don’t seem to ask so much on the phone... It 
would be nice to say to somebody, “This bit hurts, what can I do about it?  Is this any good?” and things like that.  But you need to have the 
physical and visual side of that.  [RMD 10 female age 50-54] 
 
Reduced physical activity 
Reduced planned exercise 
(including less opportunity 
or access to facilities to 
exercise) 
I think I’m so much less active, before all this I was going swimming three times a week, that was the best exercise for me really, because it didn’t 
put as much pressure on my body as going to the gym, running or anything like that.  And, I don’t think I fully appreciated how much swimming 
helped, whereas now, obviously, I’m not doing anything and I am just only getting out of the house for a little bit once a week, I’ve just found 
everywhere has just stiffened up so much…It’s a bit scary, really. [RMD5 female 25-29 ] 
 
[My joints are] getting stiff because you don’t go out much to get exercise…. sitting down a lot makes your hips an your back ache and don’t get 
up often where your chair is.  [RMD6 male 70-74] 
 
Reduced routine activity  
(e.g. walking to shops, going 
to work)  
I’ve been finding, like, sitting at my desk all day for work, I do get quite sore and quite stiff after work, because I think maybe when I was in an 
office environment I would be going out at lunchtime or just walking around the office to talk to different people…generally if I’m not sat at my 
desk working, I suppose I’m sat on the sofa, I’m not really that mobile around the house.  [RMD5 female 25-29] 
 
 [Pain and stiffness] have been a bit more apparent because I haven’t been able to get out as much and use my joints.  I find when I’ve been 
cooped up in a space and sitting down for a while, then obviously it affects you more. I can walk to work and back again and it frees things up a 
little bit.  But obviously not being able to do that, it’s not the same… it gets worse when you can’t be as mobile as you could be. [RMD12 male 35-
39] 
Working at home 
Lack of ergonomic work-
space  
At work I have a Varidesk…so, I can stand up. I also have like a proper chair, like a medical chair… [Working at home] was horrendous because I 




Struggling with household 
tasks 
I used to have someone come on a Thursday and do my chores for me…So perhaps it’s something like that as well, you know, sort of without the 
help there…. I think with the loss of energy you get more of a hurting in the legs at night and that. [RMD19 female 70-74] 
 
Wellbeing 
Managing multiple roles 
within the home  
(Home-schooling, childcare 
and work) 
I probably went way too hard on myself, trying to plan lessons for [children].  You’re also then working, you’re also trying to run the house… 
completely overdid it.…..I do think the flare that I had was related to being in lockdown.  I’m not sure I would have had it that bad if we were out 
of lockdown, because I would have been able to maybe adjust working life, the girls would have been at school, or my parents would have had 
them…. It was definitely probably reactive from overdoing it… trying to juggle so many plates. [RMD13 female 30-34] 
Anxiety or low mood 
associated with the 
pandemic and being in a 
clinically vulnerable group. 
I do struggle quite a lot with my mental health and I’ve found that my physical health has got so much worse, as well… it’s definitely harder at 
the moment. [RMD5 female 25-29] 
 
Currently, I've got swelling ….and I've got pain in multiple areas. So, I would say I'm having a flare up…maybe it's the stress had an impact on my 






In terms of my arthritis and stuff, that’s not been – touch wood – too bad.  I’ve tried to keep on top of it by trying to stay as active as I can 
really… I’ve been probably doing 2K, 3K, 5Ks a week and then us, as a family unit, we try and go for a walk…so the pain has not been too bad. 
[RMD14-male-35-39] 
Pre-existing stable or well-
controlled condition 





An opportunity for respite, 
improved wellbeing  
 
The arthritis was getting worse [and since lockdown] I’ve had no flare ups. It’s all been very much under control, and I think that’s partly being 
removed from the work situation but it’s partly having that easier pace of life, and if my body needs to sleep there's not an alarm set, it just 
sleeps.  I think before this I was feeling very tired and unwell….I now feel far calmer, physically rested, which helps no end. [RMD21 female 45-49]   
More opportunity for 
exercise 
I’m actually feeling really good right now….I like to think it’s the exercises…I’ve definitely done more daily exercises with my son and skipping and 
stuff and more bike rides.  I like cycling anyway, but I’ve been on more long bike rides and probably been taking the dog for a walk probably 
more than I’d done before.  [RMD11 female 50-54] 
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Supplementary File 1: Online survey (baseline) 
 
 





Version 0.1 - dated: 19 April 2020 
Information to help you decide if you want to take part in this research  
You are being invited to take part in a research project so we can understand how you are managing 
self-isolation during the coronavirus pandemic (Covid-19). We are particular interested in your joint 
pain, wellbeing and social contacts. Please ensure you have read and understood this information 
before continuing. 
What is this project about? 
This study aims to identify how the Covid-19 pandemic is impacting on the health and wellbeing of 
people with bone, joint or muscle pain (musculoskeletal disease). It aims to better understand how 
the current Covid-19 self-isolation is affecting people, their experiences of isolating and how they are 
managing their joint pain during this time. It will tell us about the effects of social isolation measures 
and changes in health services on people's physical health and wellbeing. The findings will be used to 
help understand who is at greatest risk of poor health and wellbeing during self-isolation so we can 
better support them during this outbreak.  
Why have I been asked? 
You have been sent this survey or have accessed it via social media. The project is entirely voluntary. 
You do not have to be in isolation to take part. 
What will taking part involve? 
You will be asked to complete a 15-minute survey online. Then every 2 weeks for the next 12 weeks, 
we will ask you to complete the same survey again. The whole study will last for about 12 weeks while 
these social isolation measures are in place. 
What will you ask and what will happen to the information I give you? 
You will be asked questions about yourself, your current joint pain, your medication and health care 
requirements for joint pain, and some questions on your physical health and wellbeing. We will also 
ask you whether you are isolating, some questions on social isolation, loneliness and resilience to this 
change in lifestyle, and some questions on your arthritis symptoms. Some of these questions are 
considered sensitive data, such as questions on your wellbeing. No information provided will be 
passed to any third parties. Your data will then be analysed by researchers from UEA and will be 
published in scientific papers and used to inform advice given during Covid-19. Nobody will be able to 
identify you from any materials we publish or present from this study.  
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You will only be identified to the research team members by your email address. We need this so that 
we can send you the follow-up fortnightly survey links for the next 12 weeks. We will not use your 
email address for any other purpose. We will not share this email address with any other people or 
organisations. 
This study has received approval from the University of East Anglia’s Faculty of Medicine and Health 
Science’s Research Ethics Committee.  
How long will my data be stored for? 
Your data will only be used for this study and not shared. Your data will be stored for 10 years by UEA 
after the end of the research. At this point the data will be reviewed, and if they are still deemed to 
be of public interest, they may be retained for longer. 
How do I find out the results? 
Researchers at UEA will provide a summary of the findings online through the UEA website. We will 
provide a hyperlink to all participants (via their email address) of this once the data has been analysed 
and reported. 
Concerns 
If you have any concerns about the study, you can contact the UEA study team at 01603 597205 or 
email noar@uea.ac.uk. If you feel your concerns have not been handled satisfactorily, you can contact 
the Dean of the Norwich Medical School (Professor William Fraser) at: W.Fraser@uea.ac.uk 
 
Consent 
By taking part, you are agreeing that you have read and understood the information above about the 
study. If you have any questions or concerns please contact 01603 597205 before agreeing to take 
part and completing the survey. 
 
I understand that: 
• My participation is completely voluntary. 
• The data gathered in this study will be stored securely and it will not be possible to identify 
me in any outputs from this research. 
• Only UEA research staff, will have access to the data. 





























Date of birth 
 





  /   /  
  
 
Email Address  





   
Male   
Age (years)   
  
What is was/your occupation:____________________________________________ 
 Are you currently: 
a. Working now  g. Homekeeper/parent/carer  
b. Unemployed  h. Student  
c. Off sick  i. Working reduced hours  
d. Retired  i. j. Working, but there has been a change 
in duties 
 
e. Not working – health grounds  k. Maternity/Paternity leave  
f. Never worked    














 Are you currently off work because of coronavirus 
self-isolation?  
     
 Are you currently working from home because of  
coronavirus self-isolation? 
     
 Which category best describes your ethnic group or background. (Tick only 
one box) 
 
 White  
 Black, Caribbean  
 Black, African  
 Any other Black background  
 Indian  
 Pakistani  
 Bangladeshi  
 Any other Asian background  
 Chinese  
 White and Black Caribbean  
 White and Black African  
 White and Asian  
 Any other mixed background  
 Any other ethnic group  
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Your Bone, Joint and Muscle Disease 
 
What is your musculoskeletal disease diagnosis? (Please tick all relevant boxes) 
 
Rheumatoid Arthritis (RA)  
Osteoarthritis (OA)  
Fibromyalgia  
Ankylosing Spondylitis  
Psoriatic Arthritis (PsA)  
Inflammatory Polyarthritis (IP)  
Mechanical Low Back Pain  
Other (please specify) 
_______________________________________ 
 
Don’t Know  
 
Where do you feel your pain? 
 
 Left Right 
Hip   
Knee   
Ankle   
Foot   
Shoulder   
Elbow   
Wrist   
Hand   
Neck  





General Health Questions  
 






Heart condition (such as heart failure or past heart 
attack) 
  
High blood pressure   
Stroke or TIA (mini stroke/transient visual loss)   
Breathing condition (such as asthma, emphysema, 
COPD) 
  
Diabetes   
Stomach Ulcer   
Liver problems   
Kidney problems   
Cancer (except skin cancer)   
Depression or Anxiety   
Glaucoma   
Dementia   
Epilepsy   
 
 
Changes since self-isolation 
 
 
Are you self-isolated for COVID-19 (i.e. not leaving home for activities other than 
shopping, exercise once daily or essential tasks)? 
❑ Yes  ❑ No 
 
Have you had difficulty accessing medications? 
❑ Yes  ❑ No 
 
Have you needed someone to help to access your medications? 
❑ Yes  ❑ No 
 
Have you had to change your medications since the COVID-19 pandemic started?  




Have you needed to seek advice from a health professional on your condition? 
❑ Yes  ❑ No 
 
Has your normal level of physical activity changed since the COVID self isolation started?  
❑ Decreased ❑ Stayed same ❑ Increased 
 
 
How has your joint pain been overall since the COVID self isolation started? 
❑ Decreased ❑ Stayed same ❑ Increased 
 
 How have your levels of energy been since the COVID self isolation started? 






Clinical Health Assessment Questionnaire (CLINHAQ) 
We are interested in learning how your illness affects your ability to function in daily life.
  
  
Please tick the response which best describes your usual abilities OVER THE PAST WEEK: 
 
 Without With With  
 any some much Unable 
 difficulty difficulty difficulty to do 
DRESSING & GROOMING:  Are you able to: 
Dress yourself, including tying shoelaces  
& doing buttons? _______ _______ _______ _______ 
Shampoo your hair? _______ _______ _______ _______ 
 
RISING:  Are you able to: 
Stand up from an armless straight chair? _______ _______ _______ _______ 
Get in and out of bed? _______ _______ _______ _______ 
 
EATING:  Are you able to: 
Cut your meat? _______ _______ _______ _______ 
Lift a full cup or glass to your mouth? _______ _______ _______ _______ 
Open a new carton of milk (or soap powder)? _______ _______ _______ _______ 
 
WALKING:  Are you able to: 
Walk outdoors on flat ground? _______ _______ _______ _______ 
Climb up five steps? _______ _______ _______ _______ 
 
Please tick any AIDS or DEVICES that you usually use for any of these activities: 
 
______ Cane (W) ______ Walking frame (W) ______ Built up or special utensils (E) 
______ Crutches (W) ______  Wheelchair (W) ______  Special or built up chair (A)  
______    Devices used for dressing (button hook, zipper pull, long handled shoe horn) (D) 




Please tick any category for which you usually need HELP FROM ANOTHER PERSON: 
________ Dressing & grooming   __________ Eating 
________ Rising    __________ Walking 
 
 
We are also interested in learning whether or not you are affected by pain because of your illness. 
 
How much pain have you had because of your arthritis IN THE PAST WEEK? 
Place a mark on the line to indicate the 
severity of the pain 
 No pain     Severe pain 
 
                        0       10       20       30        40       50       60       70       80       90       100 
How much trouble have you had with your stomach (ie nausea, heartburn, bloating, pain, etc) 
IN THE PAST WEEK?  Place a mark on the line below to indicate the severity of the problem: 
 
No stomach problem                  Severe stomach problem 
          
                     0        10        20       30       40        50        60       70       80       90       100 
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Please tick the response which best describes your usual abilities OVER THE PAST WEEK: 
 Without With With  
 any some much Unable 
 difficulty difficulty difficulty to do 
HYGIENE:  Are you able to: 
Wash and dry your entire body? _______ _______ _______ _______ 
Take a bath? _______ _______ _______ _______ 
Get on and off the toilet? _______ _______ _______ _______ 
 
REACH:  Are you able to: 
Reach and get down a 5lb object (eg a bag  
of potatoes) from just above your head? _______ _______ _______ _______ 
Bend down to pick up clothing from the floor? _______ _______ _______ _______ 
 
GRIP:  Are you able to: 
Open car doors? _______ _______ _______ _______ 
Open jars which have been previously opened? _______ _______ _______ _______ 
Turn taps on and off? _______ _______ _______ _______ 
 
ACTIVITIES:  Are you able to: 
Run errands and shop? _______ _______ _______ _______ 
Get in and out of a car? _______ _______ _______ _______ 
Do chores (vacuuming, housework or _______ _______ _______ _______ 
light gardening)? 
 
Please tick any AIDS OR DEVICES that you usually use for any of these activities: 
________ Bath rail (H) _______  Bath seat (H) 
________ Raised toilet seat (H) _______ Jar opener (for jars previously 
opened) (G) 
________ Long-handled appliances for reach (R) _______ Other (specify)  
_____________________ 
Please tick any categories for which you usually need HELP FROM ANOTHER PERSON: 
________ Hygiene _______ Gripping and opening things 
_______ Reach _______ Errands and chores  
In general, would you say that your HEALTH IS: 
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_______   Excellent _______   Good _______   Fair _______Poor 
 
Consider ALL THE WAYS THAT YOUR ARTHRITIS AFFECTS YOU. RATE HOW YOU ARE DOING on the following 
scale by placing a mark on the line below: 
         Very well                Very poorly 
          
                    0       10       20       30        40        50        60       70       80       90       100  
 
We are interested in knowing about any problems that you may have been having with fatigue. 
How much of a problem has fatigue or tiredness been for you IN THE PAST WEEK? Place a mark on the line 
below: 
 Fatigue is no problem                  Fatigue is a major problem 
          
                    0        10       20       30        40        50       60       70       80       90       100  
How much of a problem has sleep (ie resting at night) been for you IN THE PAST WEEK?  Place a mark on the 
line below: 
      Sleep is no problem                    Sleep is a major problem 
           
                    0        10       20       30        40        50        60       70       80       90       100  
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Lubben Social Network Scale-6 
 
The following 6 questions are about how often you are in contact with your family and friends. 




1 2 3 or 4 5 to 8 9 or 
more 
Family – considering the people to whom you are related by birth, marriage, adoption etc… 
How many relatives do you 
see or hear from at least 
once a month? 
      
How many relatives do you 
feel at ease with that you can 
talk about private matters? 
      
How many relatives do you 
feel close to such that you 
could call on them for help? 
      
Considering all of your friends, including those who live in your neighbourhood 
How many of your friends do 
you see or hear from at least 
once a month? 
      
How many friends do you 
feel at ease with that you can 
talk about private matters? 
      
How many friends do you 
feel close to such that you 
could call on them for help? 




University of California, Los Angeles (UCLA) three-item loneliness scale 
 
The following 3 questions are about how often you feel lonely. Please tick the box to best represent 




Some of the Time  Often  
 
How often do you feel that you lack 
companionship? 
   
How often do you feel left out?    
How often do you feel isolated from others?    
 
 




The following 6 statement relate to how ‘resilient’ you feel. Please respond to each item by marking 




Disagree Neutral Agree Strongly 
Agree 
I tend to bounce back quickly 
after hard times 
     
I have a hard time making it 
through stressful events 
     
It does not take me long to 
recover from a stressful events 
     
It is hard for me to snap back 
when something wrong 
happens 
     
I usually come through difficult 
times with little trouble 
     
I tend to take a long time to get 
over setbacks in my life 
     
 
Revised Life Orientation Test (LOT-R) 
 
Please answer the following questions about yourself. Be as honest as you can throughout and 
try not to let your responses to one question influence your response to other questions. There 




Disagree Neutral Agree Strongly 
Agree 
In uncertain times, I usually 
expect the best 
     
It’s easy for me to relax 
 
     
If something can go wrong for 
me, it will 
     
I’m always optimistic about my 
future 
     
I enjoy my friends a lot 
 
     
It’s important for me to keep 
busy 
     
I hardly ever expect things to go 
my way 
     
I don’t get upset too easily 
  
     
I rarely count on good things 
happening to me 
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Overall, I expect more good 
things to happen to me than 
bad 








We would like to thank you for completing these questionnaires. 
Your contribution is much appreciated. 
If you have any questions or queries about this form, please 
contact:  









Supplementary File 3: Interview topic guide 1 
 2 
1 How is everyday life for you at the moment? 3 
Prompts:  4 
• Getting out the house 5 
• Keeping in touch with people 6 
• Changes in routines 7 
• Changes in mood 8 
• Changes in health  9 
• Any adaptions made  10 
 11 
2 How is your joint pain? 12 
Prompts 13 
• Recent changes and what they think is the cause 14 
• Fatigue 15 
• Medication 16 
• Exercise 17 
• Self help  18 
• Contact with health professionals 19 
 20 
3 How are you managing daily tasks? 21 
Prompts 22 
• Do you usually have help shopping, cleaning 23 
• Have you made changes to the ways you do things 24 
 25 
  3a How do you feel about these changes? 26 
4 How have your social activities changed? 27 
Prompts 28 
• Keeping in touch with family and friends 29 
• Activities in the community i.e. clubs, quizzes crafts, pub 30 
• Using social media  31 
• Accessing support groups 32 
• New social contacts 33 
 34 
4a How do you feel about these changes? 35 
5 Is there anything else you would like to tell us about your life during this period? 36 





 Timepoint P-value (chi-squared) 
Baseline Week 10 
N (% of baseline) 703 (100) 490 (70)  
Age group   p=0.022 
18-60 351 (50) 212 (43)  
60 plus 351 (50) 278 (57)  
Gender   p=0.804 
Male 574 (82) 402 (83)  
Female 126 (18) 85 (17)  
MSK Diagnosis   p=0.632 
RA 321 (46) 241 (48)  
IA 41 (6) 29 (6)  
PsA 65 (9) 48 (9)  
Other 269 (39) 171 (37)  
Data are frequency (%); MSK – Musculoskeletal; RA - Rheumatoid arthritis, IA - Inflammatory 40 
arthritis; PsA - Psoriatic arthritis; Other - mainly Osteoarthritis (55%) but also including any diagnosis 41 
that was not RA, IA or PsA (see Table 1) 42 
 43 
 44 
  45 
42 
 
Supplementary File 5: Interpretive synthesis of quantitative and qualitative findings 46 
 47 
 48 
 49 
